XML 32 R3.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Income Statement [Abstract]    
Net sales $ 281,999 $ 240,472
Cost of products sold 201,559 171,615
Gross profit 80,440 68,857
Operating expenses 63,725 51,098
Operating earnings 16,715 17,759
Other income, net 880 240
Interest expense (3,862) (3,214)
Total earnings before income tax expense 13,733 14,785
Income tax expense 3,268 3,202
Net earnings 10,465 11,583
Less: net earnings attributable to the non-controlling interest 847 178
Net earnings attributable to Kewaunee Scientific Corporation $ 9,618 $ 11,405
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders    
Basic (in usd per share) $ 3.36 $ 3.98
Diluted (in usd per share) $ 3.22 $ 3.83
Weighted average number of common shares outstanding    
Basic (in shares) 2,863 2,862
Diluted (in shares) 2,983 2,979